EU-funded projects

IDF Europe welcomes the opportunity to take an active role in EU funded projects that aim at improving the health of European citizens, as these contribute to finding new treatments for diabetes and improving the lives of people living with this condition.

Developed within the EU Seventh Framework Programme (FP7), these projects encourage the development and validation of new therapies, methods for health promotion and prevention, as well as sustainable and efficient healthcare systems. IDF Europe  is currently involved in three FP7 initiatives: EuRhythdia, Eurocondor and ePredice.

EuRhythDia - Lifestyle and diabetes

Evidence has accumulated that disruption of our body’s internal clock (the so-called circadian clock) might contribute to the development of Type 2 diabetes and other cardiometabolic complications.

Few studies have investigated the link between the disruption of the daily sleep-wake pattern and Type 2 diabetes in man. For this reason, a multi-disciplinary consortium of leading academic experts and research-intensive SME’s have joined forces under EuRhythDia, the Consortium on chronotherapeutic lifestyle intervention for diabetes and obesity to reset the circadian rhythm and improve cardiometabolic risk in the European working population. This 5-year project will look at whether lifestyle change to reset the internal clock can significantly reduce the risk of developing Type 2 diabetes and cardiometabolic complications. Find out more at

Eurocondor - Preserving eyesight

A group of 17 leading European ophthalmologists and researchers have gathered together under Eurocondor, the European Consortium for the Early Treatment of Diabetic Retinopathy, with the aim of testing a new eye drop treatment that could prevent the development of diabetic retinopathy.

Diabetic retinopathy (DR) –the general term for all eye complications caused by diabetes- is the leading cause of blindness among working-age individuals in developed countries. Current treatments of DR are only indicated in advanced stages of the disease and are intrusive, costly and associated with significant side-effects. For this reason, new non-intrusive pharmacological treatments for the early stages of the disease are needed. Such new treatment could open a new field of research, reduce the socio-economic burden of treating DR, and ultimately improve the lives of people living with diabetes. For more information, visit

ePredice - Early prevention

ePredice, the Consortium for the Early Prevention of Diabetes Complications in Europe, unites 32 European academics, public healthcare professionals and SMEs with the aim to assess the effects of various medical treatments and lifestyle interventions on different microvascular complications affecting people with intermediate hyperglycaemia and screen-detected Type 2 diabetes.

This research project comes at a time where new treatments for the early prevention of diabetes complications are increasingly needed. Type 2 diabetes and Impaired Glucose Tolerance (IGT) are the major cause for morbidity and mortality due to associated complications in Europe. The economic burden is steadily rising and, with poor quality of life for people with diabetes due to chronic treatment and multiple complications, early prevention could substantially reduce the socio-economic burden of diabetes in Europe. For more informationm, visit

Involvement in other EU funded projects

IDF Europe has extensive experience in EU funded projects. Here are some links to previous EU funded projects where IDF Europe has been involved in:

  • Reniewing Health: European project aiming at implementing large-scale real-life test beds for the validation and evaluation of innovative telemedicine services by means of a patient-centred approach and a common rigorous assessment methodology. Read more.
  • SWEET: a European project to improve secondary prevention, diagnosis and control of type 1 and type 2 diabetes in children and adolescents by supporting the development of centres of reference (CORs) for pediatric and adolescent diabetes services across the EU. Read more.
  • IMAGE: a project aiming at developping and implementing a European Guideline and Training Standards for diabetes prevention. Read more.
  • DIAdvisor: a large-scale integrating project (IP) aiming at the development of a prediction based tool which uses past and easily available information to optimise the therapy of type 1 and type 2 diabetes. Read more.
  • DIAMAP: a European project to undertake a wide survey of the current European diabetes research landscape, from which expert opinion can identify gaps and highlight strengths, to guide a Road Map strategy for diabetes research in Europe. Read more.

For questions about IDF Europe's involvement in EU-funded projects, please contact Mayur Mandalia, IDF Europe Project Officer at